Maternal caffeine intake and risk of selected birth defects in the national birth defects prevention study

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 2, 2011, Pages 93-101

  Browne, Marilyn L ^a   Hoyt, Adrienne T ^a   Feldkamp, Marcia L ^b   Rasmussen, Sonja A ^c   Marshall, Elizabeth G ^d   Druschel, Charlotte M ^a   Romitti, Paul A ^e  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Birth defects; Caffeine; Coffee; Congenital abnormalities; Soft drinks; Tea

Indexed keywords

CAFFEINE; SODIUM CARBONATE;

ADOLESCENT; ADULT; ARTICLE; ATRESIA; BIRTH DEFECT; CACAO; CHILD; COFFEE; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DEMOGRAPHY; DIAPHRAGM HERNIA; DIETARY INTAKE; DISEASE ASSOCIATION; ESOPHAGUS ATRESIA; FEMALE; GASTROSCHISIS; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MATERNAL AGE; MICROTIA; NATIONAL BIRTH DEFECT PREVENTION STUDY; OMPHALOCELE; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PREVENTION STUDY; PRIORITY JOURNAL; RISK; SCHOOL CHILD; SMALL INTESTINE ATRESIA; SMALL INTESTINE DISEASE; STATISTICAL SIGNIFICANCE; TEA;

ADOLESCENT; ADULT; CAFFEINE; CASE-CONTROL STUDIES; CONGENITAL ABNORMALITIES; CRANIOSYNOSTOSES; DEMOGRAPHY; DIET; DIGESTIVE SYSTEM ABNORMALITIES; EAR; ESOPHAGEAL ATRESIA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERVIEWS AS TOPIC; INTESTINAL ATRESIA; MALE; ODDS RATIO; PREGNANCY; RISK;

EID: 79851504887     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20752     Document Type: Article

References (30)

1. Acs N, Banhidy F, Puho E, Czeizel AE. 2005. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 73: 989-996.
2. Bayley TM, Dye L, Jones S, et al. 2002. Food cravings and aversions during pregnancy: relationships with nausea and vomiting. Appetite 38: 45-51.
3. Bracken MB, Triche E, Grosso L, et al. 2002. Heterogeneity in assessing self-reports of caffeine exposure: implications for studies of health effects. Epidemiology 13: 165-171.
4. Browne ML, Bell EM, Druschel CM, et al. 2007. Maternal caffeine consumption and risk of cardiovascular malformations. Birth Defects Res A Clin Mol Teratol 79: 533-543.
5. Collier SA, Browne ML, Rasmussen SA, et al. 2009. Maternal caffeine intake during pregnancy and orofacial clefts. Birth Defects Res A Clin Mol Teratol 85: 842-849.
6. Correa A, Gilboa SM, Besser LM, et al. 2008. Diabetes mellitus and birth defects. Am J Obstet Gynecol 199: 237.e1-9.
7. Du JM, Guo WH, Han J, Zhuang HX. 2006. [Case control study on risk factors of congenital microtia]. [Article in Chinese] Zhonghua Er Bi Yan Hou Tou JingWai Ke Za Zhi 41: 107-111.
8. Frary CD, Johnson RK, Wang MQ. 2005. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105: 110-113.
9. Goh YI, Bollano E, Einarson TR, Koren G. 2006. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 28: 680-689.
10. Kirkinen P, Jouppila P, Koivula A, et al. 1983. The effect of caffeine on placental and fetal blood flow in human pregnancy. Am J Obstet Gynecol 147: 939-942.
11. Knol MJ, van der Tweel I, Grobbee DE, et al. 2007. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol 36: 1111-1118.
12. Lacroix R, Eason E, Melzack R. 2000. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol 182: 931-937.
13. Landi MT, Sinha R, Lang NP, Kadlubar FF. 1999. Human cytochrome P4501A2. IARC Sci Publ 148: 173-195.
14. Lawson CC, LeMasters GK, Levin LS, Liu JH. 2002. Pregnancy hormone metabolite patterns, pregnancy symptoms, and coffee consumption. Am J Epidemiol 156: 428-437.
15. Miller EA, Manning SE, Rasmussen SA, et al. 2009. Maternal exposure to tobacco smoke, alcohol and caffeine, and risk of anorectal atresia: National Birth Defects Prevention Study 1997-2003. Paediatr Perinat Epidemiol 23: 9-17.
16. Mintel International. 2008. Energy drink explosion hits food. Mintel Press Release. January 20, 2010. Ref Type: Electronic Citation.
17. Mose T, Kjaerstad MB, Mathiesen L, et al. 2008. Placental passage of benzoic acid, caffeine, and glyphosate in an ex vivo human perfusion system. J Toxicol Environ Health A 71: 984-991.
18. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-137.
19. Nehlig A, Debry G. 1994. Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: a review on human and animal data. Neurotoxicol Teratol 16: 531-543.
20. Nielsen GL, Nörgard B, Puho E, et al. 2005. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med 22: 693-696.
21. Rasmussen SA, Olney RS, Holmes LB, et al. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67: 193-201.
22. Rothman KJ. 1986. Modern Epidemiology. 1st edition ed. Little, Brown and Company: Boston, MA.
23. Rothman KJ, Greenland S, Lash TL. 2008. Modern Epidemiology. 3rd ed. Lippincott Williams & Wilkins: Philadelphia, PA.
24. Salvador HS, Koos BJ. 1989. Effects of regular and decaffeinated coffee on fetal breathing and heart rate. Am J Obstet Gynecol 160: 1043-1047.
25. SAS Institute Inc. 2002. SAS [computer software] Version 9.1 of the SAS System for Windows. SAS Institute Inc., Cary, NC.
26. Schmidt RJ, Romitti PA, Burns TL, et al. 2009. Maternal caffeine consumption and risk of neural tube defects. Birth Defects Res A Clin Mol Teratol 85: 879-889.
27. Slickers JE, Olshan AF, Siega-Riz AM, et al. 2008. Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study. Am J Epidemiol 168: 1259-1267.
28. Werler MM, Mitchell AA, Moore CA, et al. 2009. Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A 149A: 1399-1406.
29. Werler MM, Mitchell AA, Shapiro S. 1992. Demographic, reproductive, medical, and environmental factors in relation to gastroschisis. Teratology 45: 353-360.
30. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The National Birth Defects Prevention Study. Public Health Rep 116 Suppl 1: 32-40.